ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1347	National Cancer Institute	Html	null	Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of pancreatic neuroendocrine tumors (islet cell tumors).			CLICK HERE
1352	National Cancer Institute	Html	en	Bladder Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of bladder cancer.	bladder infections 0.409188 cancer spreads 0.362526 body 0.421643 type 0.363946 transitional cell carcinoma 0.368057 Partial cystectomy 0.367914 following PDQ summaries 0.361033 PDQ cancer information 0.437047 cancer increases 0.35829 clinical trial search 0.428286 bladder cancer 0.996648 clinical trials 0.716737 stage IV bladder 0.400568 cancer information summary 0.412718 clinical trial 0.562865 Institute about bladder 0.388854 breast cancer prevention 0.364729 superficial bladder cancer 0.471082 patients 0.385176 treatment clinical trial 0.370642 PDQ Adult Treatment 0.359776 NCI PDQ cancer 0.382156 lymph nodes 0.358627 radiation therapy 0.477016 Treatment Editorial Board 0.366853	metastatic bladder cancer 0.451959 General information 0.370997 general cancer information 0.374576 treatment 0.542299 cancer prevention 0.364857 new cancer treatments 0.373348 Recurrent bladder cancer 0.48553 NCI-supported cancer 0.389073 Cancer Information Service 0.375145 urinary diversion 0.368656 invasive bladder cancer 0.467339 treatment clinical trials 0.395244 National Cancer Institute 0.448421 radical cystectomy 0.396674 new treatment 0.433088 External radiation therapy 0.441508 Bladder Cancer Treatment 0.456321 Cancer Care page 0.36454 Blood. The cancer 0.364373 bladder cancer cells 0.466875 cancer research process 0.367381 cancer clinical trials 0.446025 cancer information summaries 0.373713 comprehensive cancer information 0.373405	CLICK HERE
1690	National Cancer Institute	Html	en	Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of pheochromocytoma and paraganglioma.	cancer treatment 0.520384 malignant tumor cells 0.51392 inherited pheochromocytoma 0.499674 metastatic pheochromocytoma 0.559666 catecholamine levels 0.546812 recurrent pheochromocytoma 0.523941 body 0.55921 PDQ cancer information 0.583541 clinical trial search 0.545652 clinical trials 0.955841 adrenal gland 0.817016 cancer information summary 0.547255 clinical trial 0.684878 blood pressure 0.689096 entire adrenal gland 0.501423 detailed pictures 0.500985 patients 0.570303 pheochromocytoma 0.843137 blood vessels 0.513601 PDQ Pheochromocytoma 0.514265 NCI PDQ cancer 0.498564 lymph nodes 0.51055 radiation therapy 0.504762 tyrosine kinase inhibitor 0.539116	benign pheochromocytoma 0.496121 treatment 0.708415 general information 0.506946 magnetic resonance imaging 0.497402 cancer cells 0.57041 adrenal cortex 0.501382 adrenal medulla 0.501576 multiple endocrine neoplasia 0.503339 treatment clinical trials 0.532049 National Cancer Institute 0.548616 tumor cells 0.524483 new treatment 0.564593 heart rate 0.509798 pheochromocytoma spreads 0.501294 pheochromocytoma cells 0.532172 Pheochromocytoma forms 0.519073 adrenal glands 0.85433 nuclear magnetic resonance 0.499251 paraganglioma 0.578972 tumors 0.523973 cancer clinical trials 0.561663 high blood pressure 0.675166 tumor 0.650897 cancer 0.88724	CLICK HERE
1715	National Cancer Institute	Html	en	Tests to Detect Colorectal Cancer and Polyps	A fact sheet that discusses the advantages and disadvantages of several colorectal cancer screening tests.	standard colonoscopy 0.642704 average risk 0.571434 sigmoidoscopy screening 0.568313 entire colon 0.614214 colorectal polyps 0.605561 abnormal growths 0.57234 colon problems 0.570159 Occult Blood Test 0.556564 early-stage colorectal cancer 0.600935 occult blood tests 0.564372 thorough cleansing 0.581775 asymptomatic colorectal cancer 0.60263 flexible lighted tube 0.561607 colorectal cancer screening 0.734621 flexible sigmoidoscopy screening 0.562785 small polyps 0.567222 digital rectal examination 0.560544 polyps 0.617192 colorectal cancer 0.956004 test 0.736074 new colorectal cancer 0.625336 guaiac FOBT 0.612613 single-specimen guaiac fobt 0.570386 inflammatory bowel disease 0.568257 ) colonoscopy. 0.566733	colon cancer incidence 0.618181 acceptable screening tests 0.563922 fecal occult blood 0.636365 colorectal cancers 0.601521 rectum 0.592026 colon tissue 0.560628 lower colon 0.576523 colon cancer mortality 0.592993 United States 0.573668 Additional procedures 0.566333 colonoscopy screening methods 0.603294 False-positive test results 0.579985 stool sample 0.563739 colorectal cancer incidence 0.613064 colon cancer 0.621651 fecal immunochemical test 0.563508 stool dna test 0.61197 people 0.593294 virtual colonoscopy 0.697133 cancer screening tests 0.581698 family history 0.558032 sigmoid colon 0.589237 colon 0.791161 et al 0.626521	CLICK HERE
1940	National Cancer Institute	Html	es	La espiritualidad en el tratamiento del cáncer (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de la influencia que tiene la espiritualidad y la religión en las personas que tienen cáncer. Se discuten varios métodos sobre manejo e intervención.	enfermos ayuda 0.452293 La espiritualidad 0.924579 términos espiritualidad 0.486044 siguientes aspectos 0.444194 Physician Data Query 0.534722	National Cancer Institute 0.427034 siguientes riesgos 0.41834 libre uso 0.416111 siguientes maneras 0.524006 Instituto Nacional 0.45946	CLICK HERE
3712	National Cancer Institute	Html	en	Understanding Precision Medicine in Cancer Treatment	Precision medicine helps doctors select cancer treatments that are most likely to help patients based on a genetic understanding of their disease. Learn about the promise of precision medicine and the role it plays in cancer treatment.	cancer treatment 0.440203 routine care 0.360336 tumor profiling 0.359671 medicine clinical trials 0.414587 type 0.382285 specific change 0.357217 new treatments 0.362099 treatments 0.484331 research 0.393932 open trials 0.357639 rectal cancers 0.362107 Targeted Cancer Therapies 0.436947 clinical trials 0.515013 cancer-causing genetic changes 0.439486 precision medicine approach 0.418811 additional genetic changes 0.428246 cancer-causing changes 0.378722 researchers 0.363172 patients 0.398147 trial staff 0.356601 cancer types 0.375159 patient care 0.366351 different types 0.361116 Tumor DNA Sequencing 0.40382 radiation therapy 0.360769	precision medicine 0.96121 person’s cancer 0.378533 genetic tests 0.37503 treatment 0.491183 precision medicine trials 0.417382 United States 0.359831 Cancer Information Service 0.419259 special lab 0.36045 targeted drug 0.368994 genetic understanding 0.381915 consent form 0.358985 different people 0.367337 Research studies 0.361413 molecular profiling 0.357183 drugs 0.382294 specific genetic changes 0.430567 certain genetic changes 0.427035 Targeted Therapy 0.372422 recent advances 0.370536 genetic changes 0.967087 specific types 0.356978 medicine clinical trial 0.490589 search tool 0.359567 cancer 0.783975	CLICK HERE
15609	National Cancer Institute	Html	es	Tratamiento de los tumores vasculares infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores vasculares infantiles.	problemas pasajeros 0.409161 lesiones benignas 0.409862 piel vecina 0.430821 efectos secundarios meses 0.423036 importantes preguntas 0.409508 siguientes especialistas 0.418218 siguientes síndromes 0.413185 rayos x 0.412063 niño ayuda 0.413721 escamas llamadas placas 0.409897 tumores benignos 0.516528 tumor vascular benigno 0.534618 Instituto Nacional 0.412348 alta potencia 0.411312 células llamadas 0.410367 tumores vasculares benignos 0.9178 venas sanas vecinas 0.421159 nuevos tipos 0.412108 sangre circula 0.414383 medicamentos propranolol hydrochloride 0.437459 angiofibroma nasofaríngeo 0.468048 hemangioendotelioma epitelioides 0.436434 once tipos 0.436191 glándula tiroides 0.427118 posibles efectos tardíos 0.424225	adultos jóvenes 0.418525 siguientes tumores 0.604051 granulomas piógenos 0.445724 hemangioma capilar lobulillar 0.505924 siguientes tipos 0.41901 ondas sonoras 0.412577 efectos tardíos 0.50862 PDQ Efectos tardíos 0.43716 vías respiratorias 0.428225 tarde.ampliar ecografía 0.413763 granuloma piógeno 0.509033 IRMN).Ampliar Imágenes 0.410245 sección opciones 0.41178 hemangioendoteliomas epitelioides 0.418326 PDQ Tratamiento 0.421361 afección llamada esclerosis 0.414532 siguientes signos 0.417619 siguientes casos 0.414811 Physician Data Query 0.425443 propranolol iv 0.42341 insuficiencia cardíaca 0.475544 hemangioma epitelioide 0.568564 siguientes pruebas 0.434586 angiofibromas nasofaríngeos juveniles 0.440153	CLICK HERE
16567	National Cancer Institute	Html	en	Pembrolizumab Improves Survival for Some Patients with Advanced Non-Small Cell Lung Cancer	A summary of clinical trial results showing that pembrolizumab improved progression-free and overall survival for patients with advanced non-small cell lung cancer.	platinum-based chemotherapy 0.628936 PD-L1 positive tumors 0.620887 advanced non-small cell 0.629259 PD-L1 expression 0.628117 1-year overall survival 0.61848 higher progression-free survival 0.617259 chemotherapy 0.698592 time patients 0.588415 chemotherapy group 0.668963 immune-mediated adverse events 0.635601 Dana-Farber Cancer Institute 0.607312 lung cancer 0.570765 biomarker. Earlier trials 0.611797 PD-L1 IHC 22C3 0.643265 immune response 0.572023 PD-L1 protein present 0.63991 overall survival 0.629887 immune-mediated deaths 0.578857 National Cancer Institute 0.604313 tumor cells 0.913581 randomized phase 0.574689 median progression-free survival 0.633329 PD-L1-expressing tumor cells 0.661448 immune therapy 0.577956	immune-mediated events 0.578589 progression-free survival 0.757999 pembrolizumab group 0.672943 platinum-based doublet chemotherapy 0.672126 standard chemotherapy 0.609699 phase III CheckMate 0.569846 patients 0.63251 trial results 0.620704 previously treated patients 0.61738 immune cells 0.61252 adverse events 0.670445 Dr. Malik 0.709776 earlier phase trial 0.627214 metastatic NSCLC 0.599852 Bruce E. Johnson 0.59961 survival advantage 0.568599 untreated advanced NSCLC 0.642891 New England Journal 0.615224 severe skin reactions 0.605442 checkpoint inhibitor pembrolizumab 0.658193 phase III trial 0.569107 Pembrolizumab blocks PD-1 0.629649 Shakun Malik 0.582607	CLICK HERE
16775	National Cancer Institute	Html	es	Cancell/Cantron/Protocel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de Cancell/Entelev como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.429084 New Hampshire Avenue 0.419912 cabo ensayos 0.419001 Drug Administration 0.412413 NCI Best Case 0.439351 tipo cancell 0.440349 mejores pruebas 0.415762 datos bibliográficos pubmed 0.42161 siguientes preguntas 0.412513 James V 0.418429 National Cancer Institute 0.425345 siguientes riesgos 0.416342 seguro médico 0.411884 Instituto Nacional 0.685274 vitamina e 0.418575 Salud Complementaria 0.444832	Visuals Online 0.415001 complementarias revisa 0.421711 Physician Data Query 0.488672 nombre cancell 0.440323 Estados Unidos 0.994944 libre uso 0.416016 suficiente actividad 0.418205 siguientes sustancias 0.422749 página manejo 0.413947 ¿El tratamiento 0.424367 ¿Los beneficios 0.412704 juntos cam 0.411781 Series Program 0.412549 medicina complementaria 0.882014 Institutos Nacionales 0.47694	CLICK HERE
16841	National Cancer Institute	Html	en	Nanotechnology Characterization Laboratory (NCL)	The Nanotechnology Characterization Laboratory (NCL) is accelerating the development of promising nanotechnology therapies and diagnostics.	extensive educational outreach 0.634447 FDA 0.244496 Nanotechnology Characterization Laboratory 0.767048 oncology-directed therapies 0.46705 great strides 0.507003 pursuit 0.246467 death rate 0.462099 Drug Administration 0.456372 unique setup 0.432854 progression 0.249487 concert 0.241265 effort 0.242009 extraordinary opportunity 0.441323 dozen NCL collaborators 0.920466 disadvantages 0.25207 relatively limited time 0.630205 biocompatibility trends 0.467853 National Cancer Institute 0.664151 National Institute 0.449153 Food 0.241207	human clinical trials 0.632541 development 0.239992 clinical translation 0.459921 therapeutic outcomes 0.469235 diagnosis 0.245742 difficult diseases 0.491415 diagnostic capabilities 0.458058 novel nanomedicines 0.45591 vast array 0.436858 different nanomaterials 0.457741 Standards 0.240975 population 0.239972 diagnostics 0.244317 advantages 0.242363 cancers 0.321573 foremost nanotechnology research 0.719052 preclinical characterization 0.513184 novel treatment strategies 0.62837 incidence 0.254427 multi-disciplinary team 0.450189	CLICK HERE